Literature DB >> 30611718

Effect of Influenza on Outcomes in Patients With Heart Failure.

Muhammad S Panhwar1, Ankur Kalra2, Tanush Gupta3, Dhaval Kolte4, Sahil Khera5, Deepak L Bhatt6, Mahazarin Ginwalla7.   

Abstract

OBJECTIVES: This study sought to determine whether influenza infection increases morbidity and mortality in patients hospitalized with heart failure (HF).
BACKGROUND: Patients with HF may be at increased risk of morbidity and mortality from influenza infection. However, there are limited data for the associated hazards of influenza infection in patients with HF.
METHODS: We queried the 2013 to 2014 National Inpatient Sample database for all adult patients (18 years of age or older) admitted with HF with and without concomitant influenza infection. Propensity score matching was used to match patients across age, race, sex, and comorbidities. Outcomes included in-hospital mortality, in-hospital complications, length of stay, and average hospital costs.
RESULTS: Of 8,189,119 all-cause hospitalizations in patients with HF, 54,590 (0.67%) had concomitant influenza infection. Patients with concomitant influenza had higher incidence of in-hospital mortality (6.2% vs. 5.4%, respectively; odds ratio [OR]: 1.15 [95% confidence interval [CI]: 1.03 to 1.30]; p = 0.02), acute respiratory failure (36.9% vs. 23.1%, respectively; OR: 1.95 [95% CI: 1.83 to 2.07]; p < 0.001), acute respiratory failure requiring mechanical ventilation (18.2% vs. 11.3%, respectively; OR: 1.75 [95% CI: 1.62 to 1.89]; p < 0.001), acute kidney injury (AKI) (30.3% vs. 28.7%, respectively; OR: 1.08 [95% CI: 1.02 to 1.15]; p = 0.01), and AKI requiring dialysis (2.4% vs. 1.8%, respectively; OR: 1.37 [95% CI: 1.14 to 1.65]; p = 0.001). Patients with influenza had longer mean lengths of stay (5.9 days vs. 5.2 days, respectively; p <0.001) but similar average hospital costs ($12,137 vs. $12,003, respectively; p = 0.40).
CONCLUSIONS: Influenza infection is associated with increased in-hospital morbidity and mortality in patients with HF. Our results emphasize the need for efforts to mitigate the incidence of influenza, specifically in this high-risk patient cohort.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heart failure; hospitalization; influenza; vaccination

Mesh:

Year:  2019        PMID: 30611718     DOI: 10.1016/j.jchf.2018.10.011

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  23 in total

1.  Influenza vaccination and mortality among adults with heart failure in an integrated healthcare delivery system, 2009-2018.

Authors:  Matthew T Mefford; Ran Liu; Katia Bruxvoort; Lei Qian; Jonathan M Doris; Sandra Y Koyama; Hung Fu Tseng; Kristi Reynolds
Journal:  J Gen Intern Med       Date:  2021-08-11       Impact factor: 6.473

2.  Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19.

Authors:  Parag Goyal; Evgeniya Reshetnyak; Sadiya Khan; Mahad Musse; Babak B Navi; Jiwon Kim; Larry A Allen; Samprit Banerjee; Mitchell S V Elkind; Sanjiv J Shah; Clyde Yancy; Erin D Michos; Richard B Devereux; Peter M Okin; Jonathan W Weinsaft; Monika M Safford
Journal:  Circ Heart Fail       Date:  2021-09-14       Impact factor: 10.447

3.  Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF).

Authors:  Phyllis Sin; Muhammad Siddiqui; Rashell Wozniak; Idris Bare; Jessica Minion; Stephen Sanche; Jacob Udell; Andrea Lavoie; Payam Dehghani
Journal:  Glob Heart       Date:  2022-06-23

4.  Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.

Authors:  Eric J Chow; Melissa A Rolfes; Alissa O'Halloran; Evan J Anderson; Nancy M Bennett; Laurie Billing; Shua Chai; Elizabeth Dufort; Rachel Herlihy; Sue Kim; Ruth Lynfield; Chelsea McMullen; Maya L Monroe; William Schaffner; Melanie Spencer; H Keipp Talbot; Ann Thomas; Kimberly Yousey-Hindes; Carrie Reed; Shikha Garg
Journal:  Ann Intern Med       Date:  2020-08-25       Impact factor: 25.391

5.  Environmental factors, winter respiratory infections and the seasonal variation in heart failure admissions.

Authors:  Doron Aronson
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

6.  Granzyme B: a double-edged sword in the response to influenza infection in vaccinated older adults.

Authors:  Chris P Verschoor; Graham Pawelec; Laura Haynes; Mark Loeb; Melissa K Andrew; George A Kuchel; Janet E McElhaney
Journal:  Front Aging       Date:  2021-11-11

7.  Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.

Authors:  Orly Vardeny; KyungMann Kim; Jacob A Udell; Jacob Joseph; Akshay S Desai; Michael E Farkouh; Sheila M Hegde; Adrian F Hernandez; Allison McGeer; H Keipp Talbot; Inder Anand; Deepak L Bhatt; Christopher P Cannon; David DeMets; J Michael Gaziano; Shaun G Goodman; Kristin Nichol; Matthew C Tattersall; Jonathan L Temte; Janet Wittes; Clyde Yancy; Brian Claggett; Yi Chen; Lu Mao; Thomas C Havighurst; Lawton S Cooper; Scott D Solomon
Journal:  JAMA       Date:  2021-01-05       Impact factor: 157.335

Review 8.  Influenza virus-related critical illness: prevention, diagnosis, treatment.

Authors:  Eric J Chow; Joshua D Doyle; Timothy M Uyeki
Journal:  Crit Care       Date:  2019-06-12       Impact factor: 9.097

9.  Readmission and mortality among heart failure patients with history of hypertension in a statewide database.

Authors:  Michail Giakoumis; Davit Sargsyan; John B Kostis; Javier Cabrera; Sanketkumar Dalwadi; William J Kostis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-07       Impact factor: 3.738

Review 10.  The immune response to influenza in older humans: beyond immune senescence.

Authors:  Janet E McElhaney; Chris P Verschoor; Melissa K Andrew; Laura Haynes; George A Kuchel; Graham Pawelec
Journal:  Immun Ageing       Date:  2020-05-07       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.